Legend Biotech (LEGN) Payables (2019 - 2025)
Legend Biotech (LEGN) posted Payables of $83.0 million for Q4 2025, down 18.99% on a QoQ basis from $102.5 million in Q3 2025, and up 115.03% year-over-year from $38.6 million in Q4 2024.
Legend Biotech (LEGN) has 7 years of Payables data on file, last reported at $83.0 million in Q4 2025.
- In Q4 2025, Payables rose 115.03% year-over-year to $83.0 million; the TTM figure through Dec 2025 stood at $83.0 million (up 115.03% YoY), while the FY2025 annual figure was $83.0 million, up 115.03% from the prior year.
- Payables retreated to $83.0 million in Q4 2025, from $102.5 million in the prior quarter.
- Across five years, Payables topped out at $102.5 million in Q3 2025 and bottomed at $7.0 million in Q4 2021.
- A 5-year average of $40.8 million and a median of $32.9 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables jumped 367.03% — and 2023, when it declined 6.8%.
- Year by year, Payables stood at $7.0 million in 2021, then jumped by 367.03% to $32.9 million in 2022, then decreased by 6.8% to $30.7 million in 2023, then climbed by 25.92% to $38.6 million in 2024, then jumped by 115.03% to $83.0 million in 2025.
- The last three Payables figures came in at $83.0 million (Q4 2025), $102.5 million (Q3 2025), and $75.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 80.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83.00 Mn |
| Sep 30, 2025 | 102.46 Mn |
| Jun 30, 2025 | 75.36 Mn |
| Mar 31, 2025 | 58.14 Mn |
| Dec 31, 2024 | 38.60 Mn |
| Sep 30, 2024 | 26.91 Mn |
| Jun 30, 2024 | 39.49 Mn |
| Mar 31, 2024 | 39.49 Mn |
| Dec 31, 2023 | 30.66 Mn |
| Sep 30, 2023 | 17.17 Mn |
| Jun 30, 2023 | 21.54 Mn |
| Mar 31, 2023 | 29.81 Mn |
| Dec 31, 2022 | 32.89 Mn |
| Mar 31, 2022 | 9.71 Mn |
| Dec 31, 2021 | 7.04 Mn |
| Dec 31, 2020 | 4.91 Mn |
| Dec 31, 2019 | 9.59 Mn |